Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001739614-21-000072
Filing Date
2021-06-08
Accepted
2021-06-08 17:22:11
Documents
1
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162318730693101.html 4  
1 FORM 4 wf-form4_162318730693101.xml 4 3982
  Complete submission text file 0001739614-21-000072.txt   5333
Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address
FORSYTH DOUGLAS (Reporting) CIK: 0001240801 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 211003079

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

EIN.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)